Intriguingly, IDH1/2 mutation sensitized primary AML cells to ABT199 by inhibiting cytochrome c oxidase (i.e., Complex IV of ETC) by 2HG[50]. This evidence concerns the gene IDH1 and acute myeloid leukemia.